logo
Rockwell Automation to Present at Wolfe's 18th Annual Global Transportation & Industrials Conference

Rockwell Automation to Present at Wolfe's 18th Annual Global Transportation & Industrials Conference

Business Wire09-05-2025
MILWAUKEE--(BUSINESS WIRE)--Rockwell Automation, Inc. (NYSE: ROK) Chairman and CEO, Blake Moret, and SVP and CFO, Christian Rothe, will present at Wolfe's 18th Annual Global Transportation & Industrials Conference on Wednesday, May 21, 2025, in New York.
The fireside chat will be webcast beginning at approximately 9:10 a.m. EDT and will be available on the Rockwell Automation Investor Relations website at www.rockwellautomation.com/en-us/investors.html.
Rockwell Automation, Inc. (NYSE: ROK), is a global leader in industrial automation and digital transformation. We connect the imaginations of people with the potential of technology to expand what is humanly possible, making the world more productive and more sustainable. Headquartered in Milwaukee, Wisconsin, Rockwell Automation employs approximately 27,000 problem solvers dedicated to our customers in more than 100 countries as of fiscal year end 2024. To learn more about how we are bringing the Connected Enterprise to life across industrial enterprises, visit www.rockwellautomation.com.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline
Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline

Yahoo

time23 minutes ago

  • Yahoo

Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline

Danaher Corp (NYSE:DHR) on Tuesday reported second-quarter 2025 sales of $5.94 billion, up 3.5% year-over-year, beating the consensus of $5.84 billion. The life science giant reported adjusted earnings of $1.80 per share, beating the consensus of $1.64. Non-GAAP core revenue increased 1.5% year over year, compared to the expectations of a growth in low single digits year over year. Operating cash flow was $1.3 billion, and non-GAAP free cash flow was $1.1 billion. Danaher's second-quarter adjusted operating profit margin of 27.3% exceeded expectations of around 25.5%.Biotechnology sales increased to $1.85 billion compared to $1.71 billion a year ago, with core growth of 6%. Sales in the Life Sciences segment remained flat at $1.78 billion, and diagnostic sales increased from $2.26 billion to $2.31 billion. The company said, "DBS-driven execution, paired with another quarter of +HSD growth in Bioprocessing and disciplined cost management, enabled us to exceed our Q2 adjusted EPS and cash flow expectations." Guidance Danaher raised fiscal 2025 adjusted earnings guidance from $7.60-$7.75 per share to $7.70-$7.80, compared to the consensus of $7.70. The company cites good traction on cost initiatives. View more earnings on DHR Danaher reaffirms that in fiscal year 2025, non-GAAP core revenue will grow by approximately 3% year over year. Cepheid 2025 respiratory revenues will be around $1.7 billion. The company expects an adjusted operating profit margin of around 25.5%. Biotechnology core revenue growth is expected to be approximately 6% for the third quarter of 2025 and around 7% for the fiscal year 2025. Life sciences core revenue will remain flat for the third quarter and fiscal year 2025. Diagnostics sales are expected to increase in the low single digits in the third quarter and flat to low single digits in fiscal year 2025. Management update Danaher announced Matthew Gugino, currently group CFO of Life Sciences Innovations Group and VP of Financial Planning & Analysis, will succeed Matthew McGrew as Danaher's CFO, effective February 28, 2026. Analyst Opinion William Blair writes that the macro backdrop for life science tools and bioprocessing companies was anything but sanguine in the second quarter, with escalating concerns surrounding the funding environment, tariffs, MFN, and whether these uncertainties resulted in a slowdown in the overall demand environment." Danaher's results suggest that was not the case, at least in the second quarter, particularly within bioprocessing. Analyst Matt Larew maintains the Outperform rating. Price Action: DHR stock is trading 0.68% higher at $189.34 at the last check on Tuesday. Read Next:Photo via Shutterstock Latest Ratings for DHR Date Firm Action From To Jan 2022 Wells Fargo Maintains Overweight Jan 2022 Barclays Maintains Overweight Jan 2022 Bernstein Initiates Coverage On Outperform View More Analyst Ratings for DHR View the Latest Analyst Ratings UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? DANAHER (DHR): Free Stock Analysis Report This article Danaher Lifts 2025 Earnings Outlook Amid Biotech Growth, Cost Discipline originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Errore nel recupero dei dati Effettua l'accesso per consultare il tuo portafoglio Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati Errore nel recupero dei dati

Lennar and Toll Brothers Shares Are Soaring, What You Need To Know
Lennar and Toll Brothers Shares Are Soaring, What You Need To Know

Yahoo

time23 minutes ago

  • Yahoo

Lennar and Toll Brothers Shares Are Soaring, What You Need To Know

What Happened? A number of stocks jumped in the afternoon session after peer, D.R. Horton reported strong quarterly results. The positive sentiment lifted the entire homebuilding sector after D.R. Horton, delivered strong third-quarter results that surpassed analyst expectations. This news appeared to overshadow broader concerns about the housing market, which included reports of stubbornly high mortgage rates and a potential slowdown. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Among others, the following stocks were impacted: Home Builders company Lennar (NYSE:LEN) jumped 8%. Is now the time to buy Lennar? Access our full analysis report here, it's free. Home Builders company Toll Brothers (NYSE:TOL) jumped 7.9%. Is now the time to buy Toll Brothers? Access our full analysis report here, it's free. Zooming In On Lennar (LEN) Lennar's shares are not very volatile and have only had 6 moves greater than 5% over the last year. In that context, today's move indicates the market considers this news meaningful, although it might not be something that would fundamentally change its perception of the business. The biggest move we wrote about over the last year was 4 months ago when the stock dropped 6.7% on the news that the company reported weak first-quarter 2025 results, with its backlog declining 22% year over year, raising concerns about the strength of its near-term sales pipeline. The more pressing issue, however, was the sharp decline in gross margin, driven by rising land costs and a slight drop in home prices. Also, while sales increased by 5%, supported by a 6% rise in home deliveries, the company had to rely on incentives, such as interest rate buydowns, which involve paying an upfront fee to reduce mortgage rates. This strategy came at a cost, leading to lower operating margins and resulting in a more than 20% year-over-year drop in EPS. Looking ahead, Lennar expects to deliver up to 20,500 homes in the second quarter, with gross margins projected to remain around 18%, reflecting continued pricing pressures. Zooming out, we think this was a decent quarter featuring some areas of strength but also some blemishes. The market seemed to focus on the negatives. Lennar is down 12% since the beginning of the year, and at $118.19 per share, it is trading 38.6% below its 52-week high of $192.45 from September 2024. Investors who bought $1,000 worth of Lennar's shares 5 years ago would now be looking at an investment worth $1,666. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.

Sinclair Acquires Assets of WDKA in Paduca, KY and KBSI in Cape Girardeau, MO
Sinclair Acquires Assets of WDKA in Paduca, KY and KBSI in Cape Girardeau, MO

Business Wire

time24 minutes ago

  • Business Wire

Sinclair Acquires Assets of WDKA in Paduca, KY and KBSI in Cape Girardeau, MO

BALTIMORE--(BUSINESS WIRE)--Sinclair today announced that it has acquired the non-licensed assets of WDKA-TV (Paducah, KY) and KBSI-TV (Cape Girardeau, MO), with an option to acquire all the licensed assets of the stations. Under the terms of the agreement, Sinclair will provide WDKA and KBSI with services including programming, technical, and management. About Sinclair: Sinclair, Inc. (Nasdaq: SBGI) is a diversified media company and a leading provider of local news and sports. The Company owns, operates and/or provides services to 180 television stations in 82 markets affiliated with all major broadcast networks; owns Tennis Channel, the premium destination for tennis enthusiasts; multicast networks CHARGE, Comet, ROAR and The Nest; and the nation's largest streaming aggregator of local news content, NewsON. Sinclair's AMP Media produces a growing portfolio of digital content and original podcasts. Additional information about Sinclair can be found at Category: General

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store